Temporal trends of HLA genotype frequencies of type 1 diabetes patients in Sweden from 1986 to 2005 suggest altered risk.

Authors: Resic-Lindehammer, S  Larsson, K  Ortqvist, E  Carlsson, A  Cederwall, E  Cilio, CM  Ivarsson, SA  Jonsson, BA  Larsson, HE  Lynch, K  Neiderud, J  Nilsson, A  Sjoblad, S  Lernmark, A  Lernmark, A  Aili, M  Bååth, L E  Carlsson, E  Edenwall, H  Forsander, G  Granstro, B W  Gustavsson, I  Hanås, R  Hellenberg, L  Hellgren, H  Holmberg, E  Hörnell, H  Ivarsson, Sten-A  Johansson, C  Jonsell, G  Kockum, K  Lindblad, B  Lindh, A  Ludvigsson, J  Myrdal, U  Neiderud, J  Segnestam, K  Sjöblad, S  Skogsberg, L  Strömberg, L  Ståhle, U  Thalme, B  Tullus, K  Tuvemo, T  Wallensteen, M  Westphal, O  Aman, J 
Citation: Resic-Lindehammer S, etal., Acta Diabetol. 2008 Dec;45(4):231-5. Epub 2008 Sep 4.
Pubmed: (View Article at PubMed) PMID:18769865
DOI: Full-text: DOI:10.1007/s00592-008-0048-5

The aim of this study was to compare the frequency of human leukocyte antigen (HLA) genotypes in 1-18-year-old patients with type 1 diabetes newly diagnosed in 1986-1987 (n = 430), 1996-2000 (n = 342) and in 2003-2005 (n = 171). We tested the hypothesis that the HLA DQ genotype distribution changes over time. Swedish type 1 diabetes patients and controls were typed for HLA using polymerase chain reaction amplification and allele specific probes for DQ A1* and B1* alleles. The most common type 1 diabetes HLA DQA1*-B1*genotype 0501-0201/0301-0302 was 36% (153/430) in 1986-1987 and 37% (127/342) in 1996-2000, but decreased to 19% (33/171) in 2003-2005 (P < 0.0001). The 0501-0201/0501-0201 genotype increased from 1% in 1986-1987 to 7% in 1996-2000 (P = 0.0047) and to 5% in 2003-2005 (P > 0.05). This study in 1-18-year-old Swedish type 1 diabetes patients supports the notion that there is a temporal change in HLA risk.

Annotation

Disease Annotations
RGD Objects Annotated

Additional Information

 
RGD Object Information
RGD ID: 2301811
Created: 2008-11-03
Species: All Species
Last Modified: 2008-11-03
Status: ACTIVE